Filing Details
- Accession Number:
- 0001209191-16-142628
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-09-23 16:50:07
- Reporting Period:
- 2016-09-21
- Filing Date:
- 2016-09-23
- Accepted Time:
- 2016-09-23 16:50:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1197023 | S Joshua Boger | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-09-21 | 6,500 | $36.30 | 274,725 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-09-21 | 1,900 | $89.73 | 272,825 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-09-21 | 2,500 | $90.77 | 270,325 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-09-21 | 1,900 | $91.82 | 268,425 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-09-21 | 200 | $92.31 | 268,225 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2016-09-21 | 6,500 | $0.00 | 6,500 | $36.30 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 105,500 | 2017-01-23 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 13,286 | Indirect | 401k |
| Common Stock | 78,200 | Indirect | Common Stock Held In Trust |
Footnotes
- Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
- Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $89.73 (range $89.21 to $90.20).
- Open market sales reported on this line occurred at a weighted average price of $90.77 (range $90.25 to $91.23).
- Open market sales reported on this line occurred at a weighted average price of $91.82 (range $91.27 to $92.21).
- Open market sales reported on this line occurred at a weighted average price of $92.31 (range $92.27 to $92.35).
- Fully vested.
Billionaire Hedge Funds
